Zimmer Biomet Holdings, Inc.

Zimmer Biomet Holdings, Inc. is a leading global medical device company specializing in the development, manufacture, and marketing of orthopedic reconstructive products. Founded in 1927 and headquartered in Warsaw, Indiana, the firm is recognized for its extensive portfolio covering joint replacement technologies, sports medicine, trauma products, extremities, spine solutions, craniomaxillofacial, thoracic implants, dental devices, and advanced surgical tools. Zimmer Biomet serves healthcare providers across the Americas, Europe, the Middle East and Africa, and Asia Pacific, reflecting a diverse and far-reaching market presence. As one of the world’s largest orthopedic companies, Zimmer Biomet is pivotal within the healthcare sector for improving patient mobility, quality of life, and surgical outcomes. Its ongoing acquisition activities, such as expanding into AI-guided surgery and biomarker diagnostics, underscore its commitment to innovation and market leadership. Operating with approximately 17,000 employees as of 2024, Zimmer Biomet is an influential component of multiple healthcare-focused exchange-traded funds, illustrating its substantial relevance to institutional investors and its strong position within global medical technology markets.